APACMed’s white paper on Laboratory-Developed Tests (LDTs) provides an overview of the regulatory landscape across 14 APAC markets. This resource highlights the fragmented nature of existing frameworks and outlines how this impacts market access, patient safety, and diagnostic reliability. The white paper aims to inform stakeholders by showcasing regulatory trends and global benchmarks, fostering dialogue, and driving awareness about the evolving regulatory environment for LDTs in the APAC region.